VIR vir.bio: Expected earnings per share growth for next year

Public company logo of vir.bio (VIR)

Vir Biotechnology, Inc. (VIR) relies on outsourcing for testing and distribution by delegating these functions to partners, which supports the growth forecasting model for next year's EPS. However, volatile cash flow and a dependence on clinical trials create risks, despite the brand's academic authority. The value of -125.70 represents the current expected profit metric, capturing the up-to-date analyst consensus on the company's revenue dynamics.

VIR: Vir Bio Consensus forecast of earnings per share growth for next year 07/04/2022 - 11/15/2026

Vir Biotechnology - analytical breakdowns and key metrics (VIR)

- price and consensus price forecast:
Summary company analysis:vir.bio, VIR
Brand item of vir.bio

This indicator measures the expected dynamics of net earnings per share, where narrowing forecast volatility often precedes a strategic revaluation of business value. For Vir Biotechnology, Inc. (VIR), the humanitarian status of its developments offsets geopolitical risks; therefore, analyzing the growth vector of next year's EPS allows for an objective assessment of the company's fundamental attractiveness, independent of external trade barriers.

Competitor analysis

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year Cidara Therapeutics, Inc.|Net earnings per share growth forecast for next year Novavax Inc (NVAX)|Consensus forecast of earnings per share growth for next year CureVac|Valneva Pharma - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year SIGA Corp (SIGA)|Emergent BioSolutions Inc - Earnings growth forecast for next year|Atea Pharmaceuticals - Projected earnings per share increase next year|IVVD (Invivyd Inc) - Expected earnings per share growth for next year|Enanta Pharmaceuticals Inc. (ENTA) - Earnings growth forecast for next year|INO (Inovio Pharma) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year HLVX|Net earnings per share growth forecast for next year Kalaris Therapeutics Inc (KLRS)|Consensus forecast of earnings per share growth for next year Dyadic International, Inc.|Earnings growth forecast for next year NNVC (nanoviricides.com)|Talphera Inc (TLPH) - Expected net earnings per share growth next year|COCP: Expected earnings per share growth for next year|Net earnings per share change forecast for next year TRAW|DWTX (Virios Therapeutics) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year QLGN|ALVR (AlloVir) - Earnings growth forecast for next year|vbivaccines.com (VBIV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year VIRI|Expected earnings per share growth for next year Vaxart Corp VXRT